SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

24 Jan 2026 Evaluate
The sales for the December 2025 quarter moved down to Rs. 211.07 millions as compared to Rs. 270.53 millions during the year-ago period.The Net Profit of the company slipped to Rs. 30.98 millions from Rs. 54.33 millions, a decline of -42.98% on QoQ basis.The Operating Profit of the company witnessed a decrease to 73.87 millions from 106.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 211.07 270.53 -21.98 760.90 841.65 -9.59 1085.96 1258.95 -13.74
Other Income 6.56 7.10 -7.61 20.08 14.43 39.15 37.30 30.71 21.46
PBIDT 73.87 106.10 -30.38 256.55 307.77 -16.64 429.42 448.77 -4.31
Interest 7.36 3.75 96.27 26.86 11.19 140.04 20.77 5.98 247.32
PBDT 66.51 102.35 -35.02 229.69 296.58 -22.55 408.65 442.79 -7.71
Depreciation 26.67 27.00 -1.22 76.74 71.42 7.45 95.67 61.10 56.58
PBT 39.84 75.35 -47.13 152.95 225.16 -32.07 312.98 381.69 -18.00
TAX 8.86 21.02 -57.85 37.91 60.15 -36.97 81.99 100.52 -18.43
Deferred Tax -7.92 0.22 -3700.00 -4.45 0.36 -1336.11 -0.45 6.74 -106.68
PAT 30.98 54.33 -42.98 115.04 165.01 -30.28 230.99 281.17 -17.85
Equity 128.38 128.43 -0.04 128.38 128.43 -0.04 128.38 125.83 2.03
PBIDTM(%) 35.00 39.22 -10.76 33.72 36.57 -7.80 39.54 35.65 10.93

Shree Ganesh Remed. Share Price

486.65 12.35 (2.60%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×